Clinical Pharmacokinetics of Aromatase Inhibitors and Inactivators

Bioequivalence of exemestane in post-menopausal females

“…h/mLreported in the literature. Onthe otherhand T max valuesof 1.5 to 2hcompared well withp ublished results [2,4].Mean elimination half-livesof 16.6hwaslowert hanthe reported 20 to27 h [4,6,9,10].…”

Bioequivalence of exemestane in post-menopausal females

“…h/mLreported in the literature. Onthe otherhand T max valuesof 1.5 to 2hcompared well withp ublished results [2,4].Mean elimination half-livesof 16.6hwaslowert hanthe reported 20 to27 h [4,6,9,10].…”

Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers with Familial Male Precocious Puberty

“…Third-generation agents (letrozole, anastrozole, and exemestane) have a pharmacokinetic profile consistent with once daily administration 22 . Because aromatase inhibitors do not reduce testosterone levels, we also administered an anti-androgen to antagonize the effects of androgens on their receptors.…”

<strong>Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs</strong>

“…Anastrozole is an aromatase inhibitor approved by the FDA to treat postmenopausal women diagnosed with advanced stage hormone receptor positive breast cancer and hormone receptor positive early stage breast cancer after surgery 139,140 . Main proteinase (3ClPro) Hits.…”

Bioequivalence of exemestane in post-menopausal females

“…h/mLreported in the literature. Onthe otherhand T max valuesof 1.5 to 2hcompared well withp ublished results [2,4].Mean elimination half-livesof 16.6hwaslowert hanthe reported 20 to27 h [4,6,9,10].…”

Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers with Familial Male Precocious Puberty

“…Third-generation agents (letrozole, anastrozole, and exemestane) have a pharmacokinetic profile consistent with once daily administration 22 . Because aromatase inhibitors do not reduce testosterone levels, we also administered an anti-androgen to antagonize the effects of androgens on their receptors.…”

<strong>Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs</strong>

“…Anastrozole is an aromatase inhibitor approved by the FDA to treat postmenopausal women diagnosed with advanced stage hormone receptor positive breast cancer and hormone receptor positive early stage breast cancer after surgery 139,140 . Main proteinase (3ClPro) Hits.…”

Bioequivalence of exemestane in post-menopausal females

“…h/mLreported in the literature. Onthe otherhand T max valuesof 1.5 to 2hcompared well withp ublished results [2,4].Mean elimination half-livesof 16.6hwaslowert hanthe reported 20 to27 h [4,6,9,10].…”

Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers with Familial Male Precocious Puberty

“…Third-generation agents (letrozole, anastrozole, and exemestane) have a pharmacokinetic profile consistent with once daily administration 22 . Because aromatase inhibitors do not reduce testosterone levels, we also administered an anti-androgen to antagonize the effects of androgens on their receptors.…”

<strong>Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs</strong>

“…Anastrozole is an aromatase inhibitor approved by the FDA to treat postmenopausal women diagnosed with advanced stage hormone receptor positive breast cancer and hormone receptor positive early stage breast cancer after surgery 139,140 . Main proteinase (3ClPro) Hits.…”